researchdrivelogo.jpg
Global Airway Management Devices Market to Garner a Revenue of $2,178.8 Million by 2026, Growing at a CAGR of 7.4% from 2019-2026 [170-Pages] | Reveals by Research Dive
09 mai 2022 09h15 HE | Research Dive
New York, USA, May 09, 2022 (GLOBE NEWSWIRE) -- According to the report published by Research Dive, the global airway management devices market is expected to generate a revenue of $2,178.8 million...
World’s largest kidney stone patient experience survey finds 60% of respondents experienced first kidney stone before the age of 45
07 févr. 2022 04h04 HE | Advanced MedTech
Singapore, Feb. 07, 2022 (GLOBE NEWSWIRE) -- Dornier MedTech publishes new insights on World Kidney Stone Day from its digital urology community which garners 45 million patient and...
Photography exhibition highlights lives of people with Chronic Kidney Disease
28 oct. 2021 03h00 HE | Quanta Dialysis Technologies
Photography exhibition highlights lives of people with Chronic Kidney Disease Quanta sponsors private viewing of Survivors: Life Unfiltered to raise awareness of chronic kidney disease ALCESTER,...
Quanta.png
New Quanta survey finds that one-third of UK dialysis patients still not offered the choice of home haemodialysis despite NICE guidelines for COVID
20 oct. 2021 07h00 HE | Quanta Dialysis Technologies
New survey finds that one-third of UK dialysis patients still not offered the choice of home haemodialysis despite NICE guidelines for COVID ALCESTER, England and BEVERLY, Massachusetts, 20 October...
Quanta.png
New Quanta survey finds that one-third of UK dialysis patients still not offered the choice of home haemodialysis despite NICE guidelines for COVID
20 oct. 2021 02h00 HE | Quanta Dialysis Technologies
New survey finds that one-third of UK dialysis patients still not offered the choice of home haemodialysis despite NICE guidelines for COVID ALCESTER, England and BEVERLY, Massachusetts, 20 October...
Expressing Gratitude to Respiratory Therapy Professionals Irving, Texas, June 04, 2021 (GLOBE NEWSWIRE) -- Respiratory disease is nothing new. Since the days of 1918 Flu, through pulmonary tuberculosis, SARS and H1N1, and even Katrina, respiratory therapy...
Collaboration to Improve Bone Health Education Published in Cancer Management and Research
11 mai 2021 09h15 HE | GRYT Health
Rochester, NY, May 11, 2021 (GLOBE NEWSWIRE) -- GRYT (“grit”) Health, a digital oncology company that empowers people to be in charge of their own health, in collaboration with Amgen, is proud to...
DBMR Logo.png
Patient Engagement Solution Market Size, Share, Industry by Latest Technology, Top Key Players, Breakdown Data by Type, Application, Regional Segment, Opportunities and COVID-19 Impact Analysis 2027
16 sept. 2020 15h07 HE | Data Bridge Market Research
PUNE, India, Sept. 16, 2020 (GLOBE NEWSWIRE) -- Data Bridge Market Research evaluated the Global Patient Engagement Solution Market 2020 through the assessment period from 2020 to 2027. As per the...
Yiviva_Logo.jpg
Yiviva Announces Dosing of First Patient in Phase 2b Study of First-Line YIV-906 Plus Sorafenib Combination Therapy in the Treatment of Hepatocellular Carcinoma
06 avr. 2020 07h00 HE | Yiviva
- First-in-class oncology therapeutic candidate YIV-906 applies an integrative systems biology approach -- Global study to evaluate efficacy, safety, and quality of life in patients with hepatitis...
首个抗肿瘤候选植物药“YIV-906”与索拉非尼联合治疗肝细胞癌的IIb期临床试验正式启动
06 avr. 2020 07h00 HE | Yiviva
—— 利用整合系统生物学方法,由耶鲁大学郑永齐教授和医起共同开发的首个抗肿瘤候选植物药 中国上海,美国纽约, April 06, 2020 (GLOBE NEWSWIRE) -- 生物制药创新企业医起医药科技有限公司(Yiviva Inc.),在2020年初正式启动了YIV-906联合索拉非尼治疗乙型肝炎相关性肝细胞癌(HCC)的一线疗法IIb期研究,并于今年三月迎来了第一位受试者。 ...